CV Sciences (CVSI) Total Current Liabilities (2011 - 2026)
CV Sciences (CVSI) reported Total Current Liabilities of $5.2 million for Q1 2026, down 1.37% on a YoY basis from $5.3 million in Q1 2025, and up 3.6% sequentially from $5.0 million in Q4 2025.
CV Sciences (CVSI) Total Current Liabilities (2011 - 2026) Analysis & Trends
CV Sciences (CVSI) has 16 years of Total Current Liabilities data on file, last reported at $5.2 million in Q1 2026.
- For the quarter ending Q1 2026, Total Current Liabilities fell 1.37% year-over-year to $5.2 million; the trailing twelve-month figure through Mar 2026 stood at $5.2 million (down 1.37% YoY), and the FY2025 full-year result was $5.0 million, down 18.15% from the prior year.
- Total Current Liabilities climbed to $5.2 million in Q1 2026, from $5.0 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $14.2 million in Q1 2022 to a low of $4.8 million in Q3 2025.
- A 5-year average of $7.6 million and a median of $6.1 million in 2023 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities advanced 9.94% in 2022 and tumbled 56.85% in 2023, its largest moves.
- Tracing CVSI's Total Current Liabilities over 5 years: stood at $13.3 million in 2022, then tumbled by 54.07% to $6.1 million in 2023, then slipped by 0.1% to $6.1 million in 2024, then declined by 18.15% to $5.0 million in 2025, then gained by 3.6% to $5.2 million in 2026.
- Business Quant data shows CVSI's Total Current Liabilities at $5.2 million in Q1 2026, $5.0 million in Q4 2025, and $4.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.56 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.53 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 18.06 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 599.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 6.81 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 831.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.66 Bn |
| 10 | CV Sciences | 3.74 Mn | 3.43 Mn | 1.56 Mn | 5.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.18 Mn |
| Dec 31, 2025 | 5.00 Mn |
| Sep 30, 2025 | 4.79 Mn |
| Jun 30, 2025 | 5.71 Mn |
| Mar 31, 2025 | 5.25 Mn |
| Dec 31, 2024 | 6.11 Mn |
| Sep 30, 2024 | 6.14 Mn |
| Jun 30, 2024 | 6.03 Mn |
| Mar 31, 2024 | 5.96 Mn |
| Dec 31, 2023 | 6.12 Mn |
| Sep 30, 2023 | 6.06 Mn |
| Jun 30, 2023 | 5.85 Mn |
| Mar 31, 2023 | 6.25 Mn |
| Dec 31, 2022 | 13.31 Mn |
| Sep 30, 2022 | 13.54 Mn |
| Jun 30, 2022 | 13.56 Mn |
| Mar 31, 2022 | 14.20 Mn |
| Dec 31, 2021 | 14.46 Mn |
| Sep 30, 2021 | 12.31 Mn |
| Jun 30, 2021 | 14.56 Mn |